KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Depreciation & Amortization - Total: 2011-2023

Historic Depreciation & Amortization - Total for TherapeuticsMD (TXMD) over the last 4 years, with Dec 2023 value amounting to $100,000.

  • TherapeuticsMD's Depreciation & Amortization - Total rose 34.86% to -$185,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $100,000, marking a year-over-year decrease of 83.33%. This contributed to the annual value of $100,000 for FY2023, which is 83.33% down from last year.
  • According to the latest figures from FY2023, TherapeuticsMD's Depreciation & Amortization - Total is $100,000, which was down 83.33% from $600,000 recorded in FY2022.
  • Over the past 5 years, TherapeuticsMD's Depreciation & Amortization - Total peaked at $600,000 during FY2022, and registered a low of $100,000 during FY2023.
  • For the 2-year period, TherapeuticsMD's Depreciation & Amortization - Total averaged around $350,000, with its median value being $350,000 (2022).
  • Data for TherapeuticsMD's Depreciation & Amortization - Total shows a maximum YoY plummeted of 83.33% (in 2023) over the last 5 years.
  • Over the past 2 years, TherapeuticsMD's Depreciation & Amortization - Total (Yearly) stood at $600,000 in 2022, then plummeted by 83.33% to $100,000 in 2023.